Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

GPT-Rosalind is an advanced reasoning model created by OpenAI, aimed at enhancing scientific exploration in fields like biology, drug development, and translational medicine. Tailored for workflows in life sciences, it assists researchers in managing extensive literature, experimental findings, and specialized databases to formulate and test innovative concepts. By integrating a profound understanding of disciplines such as chemistry, genomics, protein engineering, and disease biology with sophisticated tool-usage capabilities, it effectively interacts with scientific databases, examines experimental results, and facilitates intricate, multi-stage reasoning tasks. Its functionalities span evidence synthesis, hypothesis formulation, literature assessment, sequence analysis, and experimental design, empowering scientists to transition more swiftly from raw data to meaningful insights. Furthermore, GPT-Rosalind revolutionizes cumbersome, time-consuming research methodologies into streamlined, AI-enhanced workflows, ultimately fostering a more productive scientific environment. This model exemplifies the fusion of artificial intelligence with scientific inquiry, paving the way for groundbreaking discoveries.

Description

The foundational aspect of our immunotherapy approach lies in our comprehension of antigens and neoantigens, particularly in identifying which variations will be transcribed, translated, processed, and subsequently displayed on the surface of cells via Human leukocyte antigen (HLA) molecules, thus making them recognizable to T cells. We achieve this by employing Gritstone EDGETM, a unique platform powered by machine learning. Creating cancer immunotherapies that incorporate tumor-specific neoantigens proves challenging, mainly because tumors consist of numerous mutations, yet only a fraction of these lead to genuine tumor-specific neoantigens. To tackle this complexity, we have developed EDGE's cutting-edge integrated neural network model, trained with millions of data points gathered from a diverse range of tumor and normal tissue samples across various patient ancestries. This extensive training allows us to enhance the accuracy of neoantigen identification and improve the effectiveness of our immunotherapy strategies.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

ChatGPT
Codex CLI
OpenAI

Integrations

ChatGPT
Codex CLI
OpenAI

Pricing Details

No price information available.
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

OpenAI

Founded

2015

Country

United States

Website

openai.com/index/introducing-gpt-rosalind/

Vendor Details

Company Name

Gritstone bio

Founded

2015

Country

United States

Website

gritstonebio.com/scientific-platform/

Product Features

Alternatives

Alternatives

MIStar Reviews

MIStar

Apollo Medical Imaging Technology
MIRIO Reviews

MIRIO

DEEPLINK MEDICAL